Download presentation
Presentation is loading. Please wait.
1
Anticoagulants
2
Tow classes: Parenteral & Oral Parenteral anticoagulants:
Anticoagulants are drugs used to prevent and treat venous thrombosis (DVT) Tow classes: Parenteral & Oral Parenteral anticoagulants: Heparin and enoxaparin MOA: Antithrombin effect thrombin Fibrinogen fibrin
3
Heparin is given I. V; S. C; I. M; I. V infusion; pumps
Heparin is given I.V; S.C; I.M; I.V infusion; pumps. Heparin is effective in vivo & vitro Heparin major side effects: Bleeding. Management, stop drug and give a specific antidote to heparin protamine sulfate I.V Heparin contraindications: - Any bleeding tendency - Peptic ulcer disease
4
Low molecular weight heparin
Enoxaparin Similar to heparin but more potent Has low M.W Associated with lower incidence of bleeding Its side effects and contraindications are similar to heparin
5
Oral anticoagulants: Warfarin, phenindione (coumarins) MOA: Have an antivitamin K effect, inhibiting synthesis of vitamin K-dependent clotting factors. Effective only in vivo Given orally Start acting in 2-3 days (have delayed OOA)
6
Extensively bind plasma proteins (site of drug-drug interactions)
Many antibiotics, aspirin…↑ activity of warfarin, barbiturates ↓ its activity Warfarin is usually given with heparin (at the same time) Warfarin side effects: Bleeding, management, stop drug and give its specific antidote, vitamin K I.V
7
Warfarin contraindications:
- Bleeding tendencies - Peptic ulcer disease - During pregnancy Warfarin crosses easily the placenta and could lead to fetal abnormalities Heparin is not contraindicated during pregnancy (doesn’t cross the placenta)
8
Arterial thrombosis Management: - Eliminate risk factors, ↑ B.P; D.M; smoking; ↑ lipids… - Use of antiplatele drugs, aspirin; clopidogrel; dipyridamole… - Use of fibrinolytic (thrombolytic) drugs
9
Fibrinolytic (thrombolytic) drugs
Drugs that activate plasminogen. Convert plasminogen to plasmin → breaks down fibrin Streptokinase, given in an I.V infusion Alteplase (tissue plasminogen activator-tPA), given in an I.V infusion Anistreplase, given I.V
10
Clinical uses of fibrinolytic drugs:
- Pulmonary embolism - Acute M.I - Central DVT Disadvantages of fibrinolytic drugs: - Expensive - Frequent allergic reactions - Lead to bleeding
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.